Kannabidol or CBD, a non -psychoactive component of cannabis, inhibits nicotine metabolism, has found new research, that is, tobacco users can help prevent the next cigarette urge. Washington State University researchers managed by a team, CBD and large metabolite on human liver tissue and cell samples by testing the effects of nicotine metabolism to inhibit a key enzyme.It can allow them to wait before they feel the need for further inhalation. Philip Lazarus, Professor of WSU Pharmaceutical Sciences, said that people need more research to verify these effects and determine dosage levels, but these findings promise hope. Immunology of the best interviews, articles and news last year. "The entire mission is not nicotine, not nicotine, not nicotine, but to reduce other chemicals in tobacco smoke," Lazarus the magazine magazine in the Magazine in the Magazine in toxicology."If we could minimize this damage, it would be great for human health." is still an important health problem with one of the five people who die for smoking every year in the USA. Although it is seen as less harmful, many other nicotine distribution methods, such as vaping, sniff and chewing chemicals that may cause cancer and other diseasescontains. In this study, the researchers tested the CBD and its large metabolite, that is, in which it turned into the body, 7-Hiroxicannabidiol, on microsomes from human liver tissue and microsomes that allow them to focus on individual enzymes. CBD has found that the CBD has inhibited a few of these enzymes, including the large one for nicotine metabolism defined as CYP2A6.It looked strong and inhibited its activity at relatively low CBD concentrations by 50%. In other words, it seems that you don't need a lot of CBD to see the effect."Philip Lazarus, Professor of WSU Pharmaceutical Sciences The Lazarus team is currently developing a clinical study to examine the effects of CBD on nicotine levels in smokers, nicotine levels in their blood and smokers receive a placebo for six to eight hours.. In addition to Lazarus, the common writers of the current study include Shamema Nasrin, Shelby Coates, Keti Bardhi and Christy Watson and Joshua Muscat from the Penn State Cancer Institute.supported by. Gotopnews.com